Arcus Biosciences, Inc. (RCUS)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:49AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.42B |
| Enterprise value | 673.59M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.89 |
| Price/book (mrq) | 3.08 |
| Enterprise value/revenue | 5.76 |
| Enterprise value/EBITDA | -2.31 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.85 |
| 52-week change 3 | -12.39% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 25.47 |
| 52-week low 3 | 12.95 |
| 50-day moving average 3 | 17.41 |
| 200-day moving average 3 | 17.48 |
Share statistics
| Avg vol (3-month) 3 | 800.46k |
| Avg vol (10-day) 3 | 579.41k |
| Shares outstanding 5 | 90.95M |
| Implied shares outstanding 6 | 90.95M |
| Float 8 | 54.42M |
| % held by insiders 1 | 41.13% |
| % held by institutions 1 | 59.64% |
| Shares short (15 Apr 2024) 4 | 6.84M |
| Short ratio (15 Apr 2024) 4 | 10.43 |
| Short % of float (15 Apr 2024) 4 | 15.62% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.52% |
| Shares short (prior month 15 Mar 2024) 4 | 7.98M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -262.39% |
| Operating margin (ttm) | -293.55% |
Management effectiveness
| Return on assets (ttm) | -17.42% |
| Return on equity (ttm) | -54.87% |
Income statement
| Revenue (ttm) | 117M |
| Revenue per share (ttm) | 1.58 |
| Quarterly revenue growth (yoy) | -8.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -332M |
| Net income avi to common (ttm) | -307M |
| Diluted EPS (ttm) | -4.15 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 759M |
| Total cash per share (mrq) | 8.35 |
| Total debt (mrq) | 121M |
| Total debt/equity (mrq) | 26.19% |
| Current ratio (mrq) | 4.52 |
| Book value per share (mrq) | 6.12 |
Cash flow statement
| Operating cash flow (ttm) | -306M |
| Levered free cash flow (ttm) | -187.75M |
© 2024 Yahoo. All rights reserved.